Edge greenshoe exercised in $92.54 million initial public stock sale

Leerink Partners, Credit Suisse, Guggenheim and JMP assist with sale

By Devika Patel

Knoxville, Tenn., Oct. 6 – Edge Therapeutics, Inc. said the underwriters for its initial public offering of stock opted to exercise the deal’s $12.07 million greenshoe in full, lifting total proceeds of the offering to $92.54 million. The deal priced for $80.47 million with the greenshoe on Sept. 30.

The company sold 8,412,423 common shares at $11.00 apiece. Of the shares, 1,097,272 were part of the fully exercised greenshoe.

Leerink Partners and Credit Suisse were the bookrunning managers.

The biopharmaceutical company is based in Berkeley Heights, N.J. The company intends to apply to list its stock on the Nasdaq under the symbol “EDGE.”

Issuer:	Edge Therapeutics, Inc.
Issue:	Common stock
Amount:	$92,536,653, including $12,069,992 greenshoe of 1,097,272 shares
Shares:	8,412,423
Price:	$11.00
Warrants:	No
Bookrunners:	Leerink Partners and Credit Suisse
Co-managers:	Guggenheim Securities and JMP Securities
Pricing date:	Sept. 30
Settlement date:	Oct. 6
Stock exchange:	Nasdaq: EDGE

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.